Book a free demo with us
Book Now
CytoReason
CytoReason uses AI to transform biopharma decisions, mapping diseases with extensive data to guide research, compare drugs, and optimize drug portfolios.
Total Fundraised$5B
PE Round
Late Stage
Debt Financing
Pre-IPO
Series C
Series B
Series A
Others
2016
Tel Aviv, Israel
JPN
ISR
Biotechnology
Medical
Artificial Intelligence (AI)
51 - 200
Series B
http://www.cytoreason.com/Funding Types by Funds Raised (in USD)
Content Locked
Login or Register a FREE account to continue browsing our content
Cumulative Funding Raised Over Time
Content Locked
Login or Register a FREE account to continue browsing our content
CytoReason's Investors by Funding Rounds
| Funding Round | Announced Date | Disclosed Investors | Round Amount (USD) |
|---|
Content Locked
Login or Register a FREE account to continue browsing our content
CytoReason's Key
Team Members
Social Media
© 2024 Lucidity Insights.
